- LatestUnicef says communities 'key' to ending FGM in Africa
- LatestNigerian midwifery scheme has 'tremendously reduced' maternal deaths
- LatestMaternal mortalities 'on the rise' in Belgaum, India
- Latest‘People to People’ announces obstetrics and gynecology delegations to India and Costa Rica
- LatestNew to download: FIGO Newsletter, May 2013
- Latest‘Midwives key in the fight against maternal and newborn morbidity and mortality’
Top women's health news
The HIV rate in Swaziland remains the highest in the world, a new study has shown, with one-third of adults in the country living with the disease.
The development of new strains of sexually transmitted infection (STI) Chlamydia trachomatis is much more widespread than expected, a new men and women's health study has shown.
A team of UK researchers found DNA swapping between different variations of the disease is much easier and more common than first thought.
An oncology drug has been found to be effective at forcing HIV into a position where it can be reached by antiviral therapies.
Maternal and newborn health research has linked women's obesity with delays in mental development among very preterm infants.
Providing audio recordings of the mother's heartbeat and voice promotes better outcomes among preterm infants in neonatal units, maternal and newborn health research has found.
Maternal and newborn health researchers have suggested changes need to be made in developing countries if neonatal mortality rates are to be decreased.
Women's health research published in the journal Neurology has shown that having been pregnant in the past reduces the risk of females developing multiple sclerosis (MS).
A women's health research team at the University of Gothenburg in Sweden has made a discovery they think could improve in vitro fertilisation (IVF) success rates in the future.
The scientists have identified a molecule called Cdk1, which has a key role in the maturation of eggs.
Maternal and newborn health research has shown women taking selective serotonin reuptake inhibitors (SSRIs) during pregnancy are more likely to deliver their child prematurely, while the drugs also reduce foetal head growth.
Clinician and women's health professionals should provide information about environmental exposure risks to mothers-to-be.